Market Trends BridgeBio prices offering of $500 million convertible senior notes due 2031 (BBIO:NASDAQ)By admin8996erT0allFebruary 26, 2025 BridgeBio Pharma (NASDAQ:BBIO) Wednesday announced the pricing of $500 million aggregate principal amount of 1.75% convertible senior notes due 2031…
Market Trends BridgeBio up 7% as Q4 revenue benefits from acroamidis prescriptionsBy admin8996erT0allFebruary 20, 2025 CharlieAJA BridgeBio Pharma (NASDAQ:BBIO) is up ~7% in pre-market trading Thursday after reporting a strong year-over-year revenue gain in Q4…
